A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA)

Cancer statistics, 2014

Rebecca L. Siegel, Jiemin Ma, Zhaohui Zou et al. · CA A Cancer Journal for Clinicians · 2014 · 11.5K citations · Full text

Epidemiology Of Cancer, Cancer Registration, United States +17

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

Alan Sandler, Robert J. Gray, Michael C. Perry et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

Two pathogenetic types of endometrial carcinoma

Jan V. Bokhman · Gynecologic Oncology · 1983 · 2.5K citations

Endocrine-related Cancer, Endometriosis, Gynecology +6

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

Robert A. Burger, Mark F. Brady, Michael A. Bookman et al. · New England Journal of Medicine · 2011 · 2.3K citations · Full text

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

Marcus E. Randall, Virginia L. Filiaci, Hyman B. Muss et al. · Journal of Clinical Oncology · 2005 · 866 citations · Full text